CClinicalTrials.gg
CompletedNCT01988818CloseUpdated May 11, 2016

Prospective, Randomized Study of 2 Different Wound Dressings

An interventional study of Mepilex® Border Post-Op and standard wound dressing in Hip-surgery, Knee-surgery and Spinal-surgery, sponsored by University of Cologne. Completed at 1 site in Germany. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2016-05-11.

Sponsored by University of Cologne · Not applicable, Interventional, and Treatment

Phase
Not applicable
Study type
Interventional
Enrollment
200
Allocation
Randomized
Ages
18 Years and older
Sex
All
01

Study summary

The primary objective of this investigation is to evaluate the performance of a self-adhesive absorbent post-operative dressing coated with a soft silicone layer in minimize the risk of the development of blistering in subjects after hip or knee arthroplasty or spinal surgery in comparison to a standard wound dressing The secondary objectives are to evaluate:

  • the performance of the dressing
  • the comfort, conformability and the acceptability of the dressing
  • pain before, during and after dressing removal
  • the overall cost regarding dressing wear time, time to do dressing change and personal resources needed
Read the detailed description

A monocentre, post CE-mark, randomized clinical trial will be conducted at the University of Cologne, Department of Orthopedics and Trauma Surgery.

Male or female subjects, 18 years and above, undergoing hip, knee or spinal surgery with an expected hospital stay for 4 days or more will be included in the trial. Individual trial duration will be for 7 days (follow-up).

Two hundred subjects will be included in the trial, i.e. 100 subjects per arm. The treatment arm (either new or standard wound dressing) will be assigned by randomization stratified by type of surgery (i.e. hip, knee or spine).

AEs/ADEs/unexpected events with the device may be documented by relevant photos at time. All photos shall include a sticker marked with subject code, visit number/date and time.

Outcome Measures

Primary variable:

  • Development of blistering from day 0 to day 6 post surgery Photo documentation will be evaluated in a blinded manner by the Clinical Evaluation Committee (CEC).

Secondary variables:

  • Other wound complications (i.e. leakage, inflammation, infection)
  • Number of dressing changes
  • Pain before, during and after dressing removal (VA scale)
  • Performance and acceptability of the dressing (4 point rating scale)
02

Conditions studied

  • Hip-surgery
  • Knee-surgery
  • Spinal-surgery

Keywords

  • wound dressing
  • silicone
  • standard wound dressing
03

In context

Lead sponsor

University of Cologne is the lead sponsor of 199 studies on the registry; 26 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Age ≥18years
  2. Have an expected total length of stay of 4 or more days
  3. Undergoing elective primary arthroplasty of the hip or knee or spinal surgery
  4. Undergoing hip surgery with a standard access
  5. Give their written informed consent to participate

Exclusion criteria

Exclusion Criteria:

  1. Dressing size does not fit the incision area
  2. Known allergy/hypersensitivity to any of the components of the dressing
  3. Multi-trauma
  4. Undergoing arthroplasty or spine surgery due to tumour or infection?
  5. Fractures
  6. Wound at the surgical site prior to surgery
  7. Neurological deficit of operated side (hemiplegia, etc.)
  8. Subject has documented skin disease at time of enrolment, as judged by the investigator
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
200 participants (actual)

Study arms

  • Active comparator
    Standard wound dressing

    As comparator will be used a standard Cosmopor E®adhesive, island wound dressing (Paul Hartmann LTD)after hip or knee arthroplasty or spinal surgery

    Device: standard wound dressing

  • Experimental
    Mepilex® Border Post-Op

    wound dressing with Mepilex® Border Post-Op with Safetac®Technology, self-adherent soft silicone surgical dressing

    Device: Mepilex® Border Post-Op

Interventions

  • DeviceMepilex® Border Post-Op

    wound dressing with Mepilex® Border Post-Op with Safetac®Technology, self-adherent soft silicone surgical dressing

    Also known as: Mepilex® Border Post-Op with Safetac®Technology

  • Devicestandard wound dressing

    standard wound dressing after hip-knee or spinal surgery

    Also known as: As comparator will be used a standard Cosmopor E®adhesive, island wound dressing (Paul Hartmann LTD)

06

What researchers measure

Primary outcomes

  1. Blistering

    Development of blistering from day 0 to day 6 post surgery Photo documentation will be evaluated in a blinded manner by the Clinical Evaluation Committee (CEC).

    Time frame: 0-6 days

Secondary outcomes

  1. wound complications

    Other wound complications (i.e. leakage, inflammation, infection)

    Time frame: 0-6 days

  2. dressing changes

    Number of dressing changes

    Time frame: 0-6 days

  3. pain

    Pain before, during and after dressing removal (VA scale)

    Time frame: 0-6 days

  4. performance and acceptability

    Performance and acceptability of the dressing (4 point rating scale)

    Time frame: 0-6 days

07

Study locations

1 site
  • University Hospital Cologne
    Cologne, 50937, Germany
08

References and documents

Publications

  • Bredow J, Hoffmann K, Oppermann J, Hellmich M, Eysel P, Zarghooni K. Evaluation of Absorbent Versus Conventional Wound Dressing. Dtsch Arztebl Int. 2018 Mar 30;115(13):213-219. doi: 10.3238/arztebl.2018.0213. PubMed 29669676 ↗
  • Bredow J, Oppermann J, Hoffmann K, Hellmich M, Wenk B, Simons M, Eysel P, Zarghooni K. Clinical trial to evaluate the performance of a flexible self-adherent absorbent dressing coated with a soft silicone layer compared to a standard wound dressing after orthopedic or spinal surgery: study protocol for a randomized controlled trial. Trials. 2015 Mar 7;16:81. doi: 10.1186/s13063-015-0599-z. PubMed 25873529 ↗
09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on May 11, 2016, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT01988818
Lead sponsor
University of Cologne
Responsible party
Jan Bredow (Jan Bredow, University of Cologne) — Principal investigator
First posted
Nov 20, 2013
Start date
Apr 2014
Primary completion
Dec 2015
Completion
May 2016
Last update
May 11, 2016

Study contacts

Jan Bredow, physician
principal investigator · University Hospital of Cologne

Oversight

Data monitoring committee
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in May 2016. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion